The effect of kefir buttermilk consumption on anthropometric and blood lipid indices in patients with high blood lipids

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240308061218N1

Enrollment

Registered

2024-10-24

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia. Hyperlipidemia, unspecified

Interventions

Intervention 1: Intervention group: People with hyperlipidemia in the intervention group will be told to regularly consume kefir daily on an empty stomach for 2 months. The kefir drinks used in this s

Eligibility

Sex/Gender

All

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Willingness to cooperate Age 20-55 Years suffering from hyperlipidemia based on laboratory documentation (total cholesterol more than 240, LDL-c more than 160 and triglyceride more than 200 BMI:25-34.9

Exclusion criteria

Exclusion criteria: Unwillingness to cooperate Pregnancy, breastfeeding and menopause History of other cardiovascular diseases, diabetes, liver and kidney failure, thyroid and parathyroid diseases, chronic diseases of the digestive system and cancer Use of cigarettes, tobacco and alcohol Regular consumption of probiotic foods (kefir, probiotic yogurt) (daily consumption of kefir buttermilk or probiotic yogurt in a person's usual diet) Using food supplements that may affect metabolic parameters (prebiotics and omega 3) Intolerance or allergy to milk and dairy products Receive antibiotic treatment one month before the study Under any diet, especially the blood fat-lowering diet Taking drugs that reduce cholesterol or triglycerides

Design outcomes

Primary

Measure	Time frame
The percentage of people with hyperlipidemia( total cholesterol above 240, LDL-cholesterol above 160, triglyceride above 200 mg/dL) and The percentage of overweight people with a BMI between 25 and 34.9. Timepoint: Measurement of anthropometric indices and blood lipids at the beginning of the study (before the start of the intervention) and 60 days after the start of kefir buttermilk consumption. Method of measurement: Use Seka digital scale to measure weight, tape measure to measure height, laboratory kits of Byrex Fars company to measure blood fat indicators.	—

Measure

Time frame

The percentage of people with hyperlipidemia( total cholesterol above 240, LDL-cholesterol above 160, triglyceride above 200 mg/dL) and The percentage of overweight people with a BMI between 25 and 34.9. Timepoint: Measurement of anthropometric indices and blood lipids at the beginning of the study (before the start of the intervention) and 60 days after the start of kefir buttermilk consumption. Method of measurement: Use Seka digital scale to measure weight, tape measure to measure height, laboratory kits of Byrex Fars company to measure blood fat indicators.

—

Secondary

Measure	Time frame
Total cholesterol-LDL-TG laboratory value. Timepoint: The beginning of the study and 60 days after the start of the study. Method of measurement: medical laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hassan Entezari

Esfahan University of Medical Sciences

entezari@hlth.mui.ac.ir+98 31 3792 3172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026